Legend Biotech
- Market cap
- 3.72B
- P/E (TTM)i
- -38.24
- P/Bi
- 3.02
- EPSi
- -1.62
- Div yieldi
- 0.00%
- 52W posi
- 14%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Legend Biotech closed at 19.12, up 2.14%. That leaves the company valued at approximately 3.72B, the #2374 most valuable US-listed company we track. The 9 analysts covering the stock are, on balance, at Buy, targeting an average of 45.41 (+138%). Over the past year the stock has ranged from 16.24 to 37.50; it now sits 14% up that band.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 3 months.
- Its last 6 Sell calls were actually followed by a +6% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -35.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 7.5% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 18.72
- Open
- 18.73
- Day range
- 18.58 - 19.24
- Avg price
- 19.07
- Volume
- 1.57M
- Turnover
- 29.93M
- Turnover ratei
- 0.81%
- Volume ratioi
- 0.73
- Amplitudei
- 3.50%
- 52-week rangei
- 16.24 - 37.50
Valuation
- P/Ei
- -11.80
- P/E (TTM)i
- -38.24
- P/Bi
- 3.02
- EPSi
- -1.62
- Book value / shi
- 6.32
- Net profit
- -315.07M
- Net assets
- 1.23B
Share structure
- Market cap
- 3.72B
- Float capi
- 3.71B
- Shares out
- 194.49M
- Float sharesi
- 194.26M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-06-05
49.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-30.12M net over the window
Short interest
- Shares short
- 14.64M
- % of floati
- 7.53%
- Days to coveri
- 7.09
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Legend Biotech (LEGN)?
Legend Biotech last traded at 19.12. The quote on this page refreshes every few seconds while US markets are open.
What is Legend Biotech's market cap?
About 3.72B.
What is the P/E ratio of Legend Biotech?
The trailing twelve-month P/E is -38.24. The Valuation tab shows it against the stock's own five-year range.
Does Legend Biotech pay a dividend?
Legend Biotech does not currently pay a regular dividend.
Is Legend Biotech a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 45.41, which implies 137.5% upside from the current price. This is not investment advice.
What is Legend Biotech's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Legend Biotech a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-10-08 07:58:23 · For reference only, not investment advice and not tailored to your situation.